In the treatment of neonatal respiratory distress syndrome, the application of carnitine has the potential to reduce the need for surfactant, shorten the duration of mechanical ventilation, and reduce the incidence of bronchopulmonary dysplasia [303]
We focus on ensuring that the "reduced" form actually stays reduced until it reaches the cells that need it most
This precursor has been used in relieving asthma, cystic fibrosis, and Covid-19 and helps to thin the mucus in the lungs, improving respiratory health and inflammation (9)
The BMI considerations for GLP-1 medications extend beyond eligibility and into practical injection technique
The overall side effect profile is manageable for both sexes, but the type, intensity, and timing of symptoms follow distinct patterns